Evidence map›Paper›PMID 42387485›Full record

Observational studyBMC pregnancy and childbirth2026

Comparison of SARS-CoV-2 total and neutralizing antibody transfer to neonates from vaccinated mothers vs. mothers infected during pregnancy: an observational study.

Andrea Veronica Ojeda, Carolina Coronel-Ruiz, Ximena Carolina Romero, Jaime E Castellanos, José De la Hoz-Valle, Leonardo Bonilla-Cortés, Sandra Sanchez, Ricardo Alfonso González, Guillermo Reyes-Clavijo, Sandra Marcela Buitrago-Flechas and 2 more

Abstract readObservational StudyMulticenter StudyComparative Study
In one paragraph

Observational study in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrea Veronica OjedaFaculty of Medicine, Research Group Maternal Fetal Medicine and Gynecology El Bosque (MMFG-EB), Universidad El Bosque, Av. Carrera 9 # 131A-02, Bogotá D.C, Colombia.
Carolina Coronel-RuizVice-Chancellor of Research, Virology Group, Universidad El Bosque, Bogotá D.C, Colombia.
Ximena Carolina RomeroFaculty of Medicine, Research Group Maternal Fetal Medicine and Gynecology El Bosque (MMFG-EB), Universidad El Bosque, Av. Carrera 9 # 131A-02, Bogotá D.C, Colombia. romeroximena@unbosque.edu.co.ORCID http://orcid.org/0000-0002-7040-2705
Jaime E CastellanosVice-Chancellor of Research, Virology Group, Universidad El Bosque, Bogotá D.C, Colombia.
José De la Hoz-VallePostgraduate Division, Universidad El Bosque, Bogotá D.C, Colombia.
Leonardo Bonilla-CortésHospital Universitario Clínica San Rafael, Bogotá D.C., Colombia.
Sandra SanchezHospital Universitario Clínica San Rafael, Bogotá D.C., Colombia.
Ricardo Alfonso GonzálezCentro Policlínico del Olaya, Bogotá D.C, Colombia.
Guillermo Reyes-ClavijoCentro Policlínico del Olaya, Bogotá D.C, Colombia.
Sandra Marcela Buitrago-FlechasLos Cobos Medical Center, Bogotá D.C, Colombia.
Pedro PerdomoLos Cobos Medical Center, Bogotá D.C, Colombia.
Sandra Liliana Beltrán AcostaSubred Integrada de Servicios de Salud Suroccidente E.S.E, Bogotá D.C, Colombia.

Funding

Universidad El Bosque , Colombia PCI-2022-11095
6 · The paper itself

Abstract

backgroundDifferences in antibody production against SARS-CoV-2 arise from both, infection and immunization, leading to variations in neutralization capacity and transplacental antibody transfer during pregnancy. A deeper understanding of these mechanisms can provide valuable insights into neonatal protection against viral exposure and inform the evaluation of vaccination strategies during pregnancy. This study aimed to compare the transfer of IgG and neutralizing antibodies between neonates born to mothers vaccinated against SARS-CoV-2 either during or before gestation and those born to mothers infected during pregnancy.

methodsA multicenter cohort study was conducted across four hospitals in Bogotá, Colombia, from March to October 2023. The study assessed IgG and neutralizing antibodies in blood samples from pregnant women and umbilical cord blood from 86 mother-child pairs. The cohort comprised 40 mothers vaccinated during pregnancy (46.5%), 35 vaccinated before pregnancy (40.6%), and 11 infected with SARS-CoV-2 during pregnancy (12.8%). Statistical analysis involved Fisher's exact test for categorical variables and ANOVA for continuous variables. The Pearson correlation coefficient was employed to evaluate the correlation between maternal and umbilical cord neutralizing antibodies. Additionally, logistic regression was utilized to examine the association between neutralizing antibodies in maternal and umbilical cord blood.

resultsThe proportion of patients with positive neutralizing antibodies (defined as > 20%) differed significantly between groups, with the highest percentage observed in pregnant women vaccinated before pregnancy (85.7%). Notably, the transfer rate of neutralizing antibodies was significantly higher in infected mothers (mean = 1.0, Interquartile Range = 1.0-1.2, p = 0.014). A moderate-to-strong correlation was identified between maternal and cord neutralization percentages (r = 0.6003), irrespective of the group. Furthermore, vaccination before pregnancy (Log Odds ratio (LOR) 3.18 [95% CI 1.95-4.40]) or infection during pregnancy (LOR 2.89 [95% CI 1.17-4.61]) was associated with a higher probability of achieving a higher neutralization percentage compared to those vaccinated during pregnancy.

conclusionThis study provided evidence of maternal antibody mediated immune response to both, SARS-CoV-2 infection and COVID-19 vaccination. The findings suggest that vaccination prior to pregnancy elicits more effective antibody responses compared to vaccination during pregnancy, highlighting the effectiveness of anti-COVID-19 vaccination prior to pregnancy.

Indexed as

Antibodies, NeutralizingAntibodies, ViralCOVID-19COVID-19 VaccinesImmunity, Maternally-AcquiredPregnancy Complications, InfectiousSARS-CoV-2AdultCohort StudiesColombiaFemaleFetal BloodHumansImmunoglobulin GInfant, NewbornPregnancyAntibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesImmunoglobulin GCOVID-19 vaccinesNeutralizing AntibodiesNewbornPregnancySARS-CoV-2

Identifiers

PMID42387485
PMCPMC13617768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.